Delray Medical Center cut the ribbon on its newest high-tech machine last week that targets brain areas to treat movement ...
Biogen’s proposed acquisition comes after two difficult years of regulatory and clinical challenges, during which shares of ...
A yearslong partner of neuroscience player Sage, Biogen already owns 10.2% of the Cambridge, Massachusetts-based biotech, ...
Sage Therapeutics Inc. (NASDAQ:SAGE) confirmed that Biogen Inc. (NASDAQ:BIIB) submitted an unsolicited, nonbinding proposal ...
Three blockbuster-potential assets in late-stage clinical trials and four pivotal readouts expected in 2025; anticipate four commercial assets by ...
Three blockbuster-potential assets in late-stage clinical trials and four pivotal readouts expected in 2025; anticipate four commercial assets by 2028 Study 1 of Essential3 program for ulixacaltamide ...
The $7.22-per-share deal for 89.8% of Sage is a 30% premium on the company's share price on Friday and is estimated by ...
Hosted on MSN4d
Is Parkinson's Disease Infectious?Researchers do not deny that infections like influenza, herpes and Hepatitis-C an lead to Parkinson's disease. However, more ...
The Miami Neuroscience Center at Larkin Hospital in South Miami has successfully performed its first focused ultrasound ...
Aotearoa New Zealand, Australia and Pacific island nations are the only countries that remain free of highly pathogenic avian ...
NeuroOne Medical Technologies Corporation filed an 8-K form with the Securities and Exchange Commission, announcing certain preliminary financial results for the first fiscal quarter of 2025, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback